Clinical Trials Browser

Phase 2 × Telmisartan × Gynecologic × Clear all

NCT06815497 2026-01-28

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

Phase 2 Recruiting

Ovarian Neoplasms

NCT05322889 2024-08-28

PrevTel

Phase 2 Completed

BreastGynecologic

Breast Neoplasms, Neuralgia, Ovarian Neoplasms